Karuna Therapeutics, Inc.
KRTXDelisted Mar 18, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001771917
Karuna Therapeutics, Inc. was delisted on Mar 18, 2024; its insiders filed their last Form 4 on Mar 18, 2024; 328 institutions reported holding it in 13F filings for Q4 2023, worth $12.0B in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Karuna Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 256
- +62 vs. Q2 2022
- Shares held
- 34.0M
- +4.16M (+13.9%) vs. Q2 2022
- Total value
- $7.65B
- +$3.88B (+102.9%) vs. Q2 2022
- New holders
- 85
- 89 more added
- Sold out
- 23
- 68 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KRTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 2 | $269.8K |
| Q4 2023 | 328 | $12.0B |
| Q3 2023 | 257 | $6.46B |
| Q2 2023 | 289 | $8.16B |
| Q1 2023 | 247 | $7.02B |
| Q4 2022 | 248 | $6.81B |
| Q3 2022 | 256 | $7.65B |
| Q2 2022 | 195 | $3.77B |
| Q1 2022 | 178 | $3.73B |
| Q4 2021 | 171 | $3.83B |
| Q3 2021 | 159 | $3.13B |
| Q2 2021 | 160 | $2.93B |
| Q1 2021 | 157 | $3.02B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Karuna Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Candriam Luxembourg S.C.A. | 82,201 | $18.5M | 0.13% | −6,526−7.4% | Reduced |
| Driehaus Capital Management LLC | 83,465 | $18.8M | 0.28% | +83,465 | New |
| Citadel Advisors LLC | 83,841 | $18.9M | 0.02% | +64,222+327.3% | Added |
| Atika Capital Management LLC | 91,000 | $20.5M | 2.32% | +38,000+71.7% | Added |
| Fiera Capital Corp | 101,640 | $20.7M | 0.07% | +101,640 | New |
| Emerald Mutual Fund Advisers Trust | 96,706 | $21.8M | 1.37% | −5,265−5.2% | Reduced |
| Nuveen Asset Management, LLC | 96,986 | $21.8M | 0.01% | +21,681+28.8% | Added |
| UBS Asset Management Americas Inc | 105,553 | $23.7M | 0.01% | −59,156−35.9% | Reduced |
| Clarius Group, LLC | 109,966 | $24.7M | 2.47% | +104,514+1,917.0% | Added |
| Emerald Advisers, LLC | 119,828 | $27.0M | 1.39% | −700−0.6% | Reduced |
| Eagle Asset Management Inc | 120,309 | $27.1M | 0.18% | −5,133−4.1% | Reduced |
| Dimensional Fund Advisors LP | 120,865 | $27.2M | 0.01% | −10,728−8.2% | Reduced |
| Pictet Asset Management SA | 124,161 | $27.9M | 0.04% | +4,430+3.7% | Added |
| Artal Group S.A. | 125,000 | $28.1M | 1.47% | +125,000 | New |
| PFM Health Sciences, LP | 130,293 | $29.3M | 1.12% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 135,000 | $30.4M | 0.08% | −140,000−50.9% | Reduced |
| Morgan Stanley | 146,144 | $32.9M | 0.00% | −6,788−4.4% | Reduced |
| Logos Global Management LP | 150,000 | $33.7M | 4.16% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 150,000 | $33.7M | 2.37% | +25,000+20.0% | Added |
| Goldman Sachs Group Inc | 156,246 | $35.1M | 0.01% | −30,631−16.4% | Reduced |
| Voloridge Investment Management, LLC | 163,627 | $36.8M | 0.20% | +163,627 | New |
| First Light Asset Management, LLC | 166,316 | $37.4M | 3.79% | +40,523+32.2% | Added |
| Miller Value Partners, LLC | 170,335 | $38.3M | 2.33% | −52,620−23.6% | Reduced |
| Ensign Peak Advisors, Inc | 175,813 | $39.5M | 0.10% | −40,144−18.6% | Reduced |
| Franklin Resources Inc | 196,912 | $44.3M | 0.02% | −53,367−21.3% | Reduced |
| Two Sigma Investments, LP | 209,962 | $47.2M | 0.16% | +209,962 | New |
| Charles Schwab Investment Management Inc | 217,515 | $48.9M | 0.02% | +46,168+26.9% | Added |
| Bank of New York Mellon Corp | 218,802 | $49.2M | 0.01% | −45,537−17.2% | Reduced |
| Hood River Capital Management LLC | 227,483 | $51.2M | 1.96% | +103,331+83.2% | Added |
| Brown Advisory Inc | 229,913 | $51.7M | 0.10% | +229,913 | New |
| Nan Fung Group Holdings Ltd | 241,639 | $54.4M | 34.69% | +15,951+7.1% | Added |
| Norges Bank | 261,109 | $58.7M | 0.02% | +63,436+32.1% | Added |
| Northern Trust Corp | 263,155 | $59.2M | 0.01% | +31,275+13.5% | Added |
| Point72 Asset Management, L.P. | 268,100 | $60.3M | 0.26% | +268,100 | New |
| Invesco Ltd. | 306,895 | $69.0M | 0.02% | +293,854+2,253.3% | Added |
| D. E. Shaw & Co., Inc. | 318,120 | $71.6M | 0.13% | +312,660+5,726.4% | Added |
| Renaissance Technologies LLC | 350,000 | $78.7M | 0.11% | +323,000+1,196.3% | Added |
| Rock Springs Capital Management LP | 413,762 | $93.1M | 2.40% | −28,131−6.4% | Reduced |
| General Atlantic LLC | 415,000 | $93.3M | 1.10% | +415,000 | New |
| Avidity Partners Management LP | 431,800 | $97.1M | 2.11% | +227,230+111.1% | Added |
| Geode Capital Management, LLC | 505,851 | $113.8M | 0.02% | +81,451+19.2% | Added |
| Eventide Asset Management, LLC | 519,700 | $116.9M | 2.30% | −99,700−16.1% | Reduced |
| Alliancebernstein L.P. | 525,490 | $118.2M | 0.06% | +398,898+315.1% | Added |
| Lord, Abbett & Co. LLC | 694,778 | $156.3M | 0.57% | +412,548+146.2% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 765,895 | $172.3M | 62.95% | −115,563−13.1% | Reduced |
| State Street Corp | 876,845 | $197.2M | 0.01% | −311,592−26.2% | Reduced |
| T. Rowe Price Investment Management, Inc. | 973,257 | $218.9M | 0.17% | +973,257 | New |
| Wellington Management Group LLP | 1,001,103 | $225.2M | 0.05% | +62,954+6.7% | Added |
| Viking Global Investors LPSuperinvestorViking Global Investors | 1,014,116 | $228.1M | 1.05% | −105,244−9.4% | Reduced |
| ARCH Venture Management, LLC | 1,312,872 | $295.3M | 38.28% | −1,600,000−54.9% | Reduced |
| Capital International Investors | 1,695,579 | $381.4M | 0.11% | +664,845+64.5% | Added |
| Sofinnova Investments, Inc. | 2,073,124 | $466.3M | 29.65% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 2,216,146 | $498.5M | 0.08% | +191,307+9.4% | Added |
| BlackRock Inc. | 2,257,694 | $507.8M | 0.02% | +371,050+19.7% | Added |
| Vanguard Group Inc | 2,621,585 | $589.7M | 0.02% | +448,871+20.7% | Added |
| FMR LLC | 4,451,209 | $1.00B | 0.10% | −31,199−0.7% | Reduced |
| Great Point Partners LLC | 0 | $0 | 0.00% | −149,000−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Casdin Capital, LLC | 0 | $0 | 0.00% | −85,000−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −72,802−100.0% | Sold out |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −69,966−100.0% | Sold out |
| Impax Asset Management Group plc | 0 | $0 | 0.00% | −49,463−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −45,000−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −29,900−100.0% | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −21,510−100.0% | Sold out |
| MPM Oncology Impact Management LP | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −14,294−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −12,655−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −10,730−100.0% | Sold out |
| DLD Asset Management, LP | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −7,368−100.0% | Sold out |
| CSS LLC | 0 | $0 | 0.00% | −5,676−100.0% | Sold out |
| Worth Venture Partners, LLC | 0 | $0 | 0.00% | −4,800−100.0% | Sold out |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −3,898−100.0% | Sold out |
| Winton Group Ltd | 0 | $0 | 0.00% | −3,719−100.0% | Sold out |
| Cornerstone Wealth Management, LLC | 0 | $0 | 0.00% | −1,805−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −1,083−100.0% | Sold out |
| International Biotechnology Trust PLC | 0 | $0 | 0.00% | −1,567−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −82−100.0% | Sold out |
| Exane Derivatives | – | – | – | – | Not filed |